{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:47:35Z","timestamp":1792741655137,"version":"4.5.0"},"reference-count":43,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The U.S. Public Health Service and the Institute of Medicine recommend that all women capable of becoming pregnant consume 400\u2009\u03bcg of folic acid daily to help prevent neural tube defects (NTDs). Hispanic women are at higher risk of having babies with NTDs than non-Hispanic White women. This study assessed multivitamin (MV) use, a main source of folic acid, among Hispanic women of reproductive age using a survey of solely U.S. Hispanic adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      MV use was assessed as part of Porter Novelli's\n                      <jats:italic toggle=\"yes\">Estilos<\/jats:italic>\n                      survey, fielded annually through the largest online U.S. Hispanic panel, Offerwise's QueOpinas. During the study period of 2013\u20132022, 9,999 surveys were completed; selection was weighted to match the U.S. Census American Community Survey proportions. Log-binomial regression models were applied to estimate MV use trends by age groups, acculturation levels, and pregnancy intention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 3,700 Hispanic women of reproductive age, overall no MV use increased from 39.3% in 2013 to 54.7% in 2022 (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      for trend &lt;0.0001), especially among Hispanic women aged 18\u201334 years and those classified as acculturated. Among women planning to get pregnant, daily MV use was 31.1% in 2013 compared with 18.7% in 2020\u20132022 (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Given the increase in no MV use among Hispanic women of reproductive age, targeted interventions may help reach at-risk groups for NTDs prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jwh.2023.0380","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T11:12:02Z","timestamp":1712056322000},"page":"629-638","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Multivitamin Use Among Hispanic Women of Reproductive Age in the United States, 2013\u20132022"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-3535","authenticated-orcid":false,"given":"Kaitlyn","family":"Long","sequence":"first","affiliation":[{"name":"Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA."},{"name":"Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara T.","family":"Mai","sequence":"additional","affiliation":[{"name":"Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yue","sequence":"additional","affiliation":[{"name":"Eagle Global Scientific LLC., San Antonio, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine F.","family":"Yeung","sequence":"additional","affiliation":[{"name":"Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911113412001"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007950.pub3"},{"issue":"14","key":"e_1_3_7_5_2","first-page":"1","article-title":"Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects","volume":"41","author":"Centers for Disease Control and Prevention","year":"1992","unstructured":"Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep, 1992; 41(RR-14):1\u20137.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"key":"e_1_3_7_6_2","unstructured":"Institute of Medicine. Dietary Reference Intakes for Thiamin Riboflavin Niacin Vitamin B6 Folate Vitamin B12 Pantothenic Acid Biotin and Choline. The National Academies Collection: Reports Funded by National Institutes of Health. National Academies Press: Washington DC USA; 1998."},{"issue":"31","key":"e_1_3_7_7_2","first-page":"980","article-title":"CDC Grand Rounds: Additional Opportunities to Prevent Neural Tube Defects with Folic Acid Fortification","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: Additional Opportunities to Prevent Neural Tube Defects with Folic Acid Fortification. MMWR Morb Mortal Wkly Rep, 2010; 59(31):980\u2013984.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"e_1_3_7_8_2","first-page":"8750","article-title":"Food Labeling: Health Claims and Label Statements; Folate and Neural Tube Defects; Revocation","volume":"61","author":"The Food and Drug Administration (FDA)","year":"1996","unstructured":"The Food and Drug Administration (FDA). Food Labeling: Health Claims and Label Statements; Folate and Neural Tube Defects; Revocation. Fed Regist, 1996; 61(44):8750\u20138751.","journal-title":"Fed Regist"},{"issue":"1","key":"e_1_3_7_9_2","first-page":"1","article-title":"Updated estimates of neural tube defects prevented by mandatory folic Acid fortification\u2014United States, 1995\u20132011","volume":"64","author":"Williams J","year":"2015","unstructured":"Williams J, , Mai CT, , Mulinare J, et al. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification\u2014United States, 1995\u20132011. MMWR Morb Mortal Wkly Rep, 2015; 64(1):1\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23378"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.110.004671"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2013.4695"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.01.025"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.5.1409"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.3402\/fnr.v57i0.19146"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980012004582"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2017.11.003"},{"key":"e_1_3_7_18_2","unstructured":"U.S. Food and Drug Administration. FDA Approves Folic Acid Fortification of Corn Masa Flour. FDA; 2020. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-folic-acid-fortification-corn-masa-flour [Last accessed: October12 2023]."},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041325"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2018.7075"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.14403"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23597"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.3945\/jn.111.143412"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6701a1"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20582"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20584"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3016.2006.00722.x"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/0739986303025002001"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/mcn.12134"},{"key":"e_1_3_7_30_2","unstructured":"United States Census Bureau. Race and Ethnicity in the United States: 2010 Census and 2020 Census; n.d. Available from: https:\/\/www.census.gov\/library\/visualizations\/interactive\/race-and-ethnicity-in-the-united-state-2010-and-2020-census.html [Last accessed: October12 2023]."},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-006-0104-0"},{"issue":"1","key":"e_1_3_7_32_2","first-page":"5","article-title":"Use of supplements containing folic acid among women of childbearing age\u2014United States, 2007","volume":"57","author":"Petrini JR","year":"2008","unstructured":"Petrini JR, , Hamner HC, , Flores AL, et al. Use of supplements containing folic acid among women of childbearing age\u2014United States, 2007. MMWR Morb Mortal Wkly Rep, 2008; 57(1):5\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"17","key":"e_1_3_7_33_2","first-page":"1","article-title":"Births: Final Data for 2020","volume":"70","author":"Osterman M","year":"2021","unstructured":"Osterman M, , Hamilton B, , Martin JA, et al. Births: Final Data for 2020. Natl Vital Stat Rep, 2021; 70(17):1\u201350.","journal-title":"Natl Vital Stat Rep"},{"issue":"10","key":"e_1_3_7_34_2","first-page":"1","article-title":"Preconception and interconception health status of women who recently gave birth to a live-born infant\u2014Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004","volume":"56","author":"D'Angelo D","year":"2007","unstructured":"D'Angelo D, , Williams L, , Morrow B, et al. Preconception and interconception health status of women who recently gave birth to a live-born infant\u2014Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ 2002, 2007; 56(10):1\u201335.","journal-title":"MMWR Surveill Summ 2002"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003657"},{"issue":"3","key":"e_1_3_7_36_2","first-page":"1","article-title":"Core state preconception health indicators: Pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009","volume":"63","author":"Robbins CL","year":"2014","unstructured":"Robbins CL, , Zapata LB, , Farr SL, et al. Core state preconception health indicators: Pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009. MMWR Surveill Summ 2002, 2014; 63(3):1\u201362.","journal-title":"MMWR Surveill Summ 2002"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6620a1"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2011.04.009"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1506575"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.10.027"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqy065"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-020-03055-6"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/1524839906289167"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2016.6116"}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2023.0380","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2023.0380","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2023.0380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:48:18Z","timestamp":1785480498000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jwh.2023.0380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1089\/jwh.2023.0380"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2023.0380","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]}}}